Are oxidative stress markers helpful for diagnosing the disease and determining its complexity or extent in patients

Mustafa Yılmaz1, Cihan Altın, Afag Özyıldız

  • 1Department of Cardiology, Başkent University Faculty of Medicine, Adana, Turkey. yilmazmustafa2001@yahoo.com.

Insights

Patients with coronary artery disease (CAD) show higher oxidative stress (malondialdehyde) and lower antioxidant capacity (TAOC). However, these markers do not predict disease complexity in stable CAD.

Area of Science:

  • Cardiology
  • Biochemistry
  • Oxidative Stress Research

Background:

  • Coronary artery disease (CAD) is a significant health concern.
  • Oxidative and antioxidative stress markers are implicated in various cardiovascular conditions.
  • Understanding these markers' role in CAD diagnosis and complexity is crucial.

Purpose of the Study:

  • To investigate the relationship between oxidative/antioxidative stress markers and the diagnosis of coronary artery disease (CAD).
  • To explore the association between these markers and the complexity of CAD in patients with stable CAD.

Main Methods:

  • 145 patients were categorized into non-CAD and CAD groups based on coronary angiography.
  • Patients with CAD were further stratified by SYNTAX score into low and moderate/high complexity groups.
  • Serum malondialdehyde (MDA) and total antioxidant capacity (TAOC) levels were measured and compared between groups.

Main Results:

  • Significantly higher serum MDA and lower TAOC levels were observed in patients with CAD compared to those without (p=0.036 and p=0.029).
  • No significant differences in MDA or TAOC levels were found between low and moderate/high complexity CAD groups (p=0.582 and p=0.85).

Conclusions:

  • Serum MDA and TAOC levels can differentiate patients with stable CAD from those without.
  • These oxidative/antioxidative stress markers do not appear to predict the complexity of coronary artery disease in stable patients.
Abstract

Related Concept Videos

Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
316
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
630
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
1.3K
Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
963
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
489
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
1.2K